Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction
- 1 August 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (15), 1819-1824
- https://doi.org/10.1016/0960-894x(96)00323-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Nitric Oxide: A Physiologic Mediator of Penile ErectionScience, 1992
- Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agentsBiochemical Society Transactions, 1992
- Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic NeurotransmissionNew England Journal of Medicine, 1992
- Endothelium‐dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitorsBritish Journal of Pharmacology, 1991
- cGMP: The wayward child of the cyclic nucleotide familyTrends in Neurosciences, 1991
- A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle.Journal of Clinical Investigation, 1991
- Comparative hemodynamic and renal effects of the low Km cGMP phosphodiesterase inhibitors cicletanine and zaprinast in anesthetized dogsDrug Development Research, 1991
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diureticBiochemical and Biophysical Research Communications, 1989
- Antiallergenic 8-azapurines. 3. Structural characterization of 2-(2-propoxyphenyl)-8-azahypoxanthine, 2-[2-propoxy-5-(propylsulfonyl)phenyl]-8-azahypoxanthine, and 2-[2-propoxy-5-(N-methyl-N-isopropylsulfamoyl)phenyl]-8-azahypoxanthineJournal of the American Chemical Society, 1982